製藥和生物技術領域的共同推廣和聯合行銷（2016-2025）

《製藥和生物技術領域的聯合促銷和聯合行銷交易》深入理解和分析了公司如何以及為何達成聯合促銷和聯合行銷交易。

本報告提供了 2016 年至 2025 年聯合推廣和聯合行銷交易的詳細資訊。

本報告提供雙方宣布的聯合促銷和聯合行銷交易的付款條款。這些數據為付款條款和其他貿易條款提供了寶貴的見解。

了解潛在合作夥伴談判的交易條款的靈活性可以為談判過程提供重要的見解，讓您了解在談判條款時會發生什麼。許多中小企業可能會要求詳細的付款條款，但當涉及如何觸發付款和權利轉移時，細節決定成敗。

本報告提供了當前協議交易和合作夥伴關係資料庫中記錄的自 2016 年以來宣布的聯合推廣和聯合營銷交易的綜合列表，以及可用的財務條款，以及公司及其合作夥伴向美國證券交易委員會提交的實際聯合推廣和聯合營銷交易文件的在線副本鏈接。

報告的第一章描述了共同推廣和聯合行銷交易和商業活動。

第 1 章對報告進行了介紹，第 2 章對聯合促銷和聯合行銷趨勢進行了概述和分析，並討論了每種交易類型的好處。

第 3 章概述了聯合促銷和聯合行銷交易結構。

第 4 章回顧了 2016 年以來的主要聯合推廣和聯合行銷專案。交易按標題金額列出。如果交易已與美國證券交易委員會 (SEC) 公佈了協議，您可以透過此連結透過目前協議交易和聯盟資料庫在線存取協議。

第 5 章提供了最活躍的 25 家聯合推廣和聯合行銷交易商的綜合清單。每個交易標題都透過當前協議交易和聯盟資料庫連結到完整的線上交易記錄，並連結到可用的實際協議文件，從而可以輕鬆、按需存取每個交易記錄。

第 6 章對 2016 年以來達成或宣布的聯合推廣和聯合行銷交易進行了全面深入的回顧，其中提供了合約文件，按公司 A-Z、療法、技術和行業進行組織。合約文件詳細介紹了雙方就聯合推廣和聯合行銷協議達成的實際條款和條件。

交易目錄包含自 2016 年以來宣布的所有聯合推廣和聯合行銷交易的綜合清單。每個清單都按公司 A-Z、治療領域和技術類型組織成交易目錄。每個交易標題都透過超連結連結到交易記錄的線上版本，包括實際的合約文件（如果有）。

該報告還包含大量圖表和圖形，展示了自 2016 年以來聯合推廣和聯合行銷交易的趨勢和活動。

總之，我們提供了潛在交易者需要了解的所有關於共同推廣和聯合行銷交易的資訊。

目錄

摘要整理

第1章 -簡介

第2章 聯合促銷與聯合行銷的交易趨勢

• 簡介
• 聯合促銷與聯合行銷交易定義
• 2016年以後的聯合促銷與聯合行銷交易趨勢
  • 聯合促銷與聯合行銷交易數量，各年度，2016年～2025年
  • 聯合促銷與聯合行銷交易，各開發階段，2016年～2025年
  • 聯合促銷與聯合行銷交易，2016年～2025年，各業界
  • 聯合促銷與聯合行銷交易，2016年～2025年，各治療領域
  • 聯合促銷與聯合行銷交易，2016年～2025年，各技術類型
  • 最活躍的各企業聯合促銷與聯合行銷的交易，2016年～2025年
• 為什麼要簽訂共同推廣和聯合行銷合作協議？
• 共同推廣與聯合行銷交易的未來

第3章 聯合促銷與聯合行銷的交易結構概要

• 簡介
• 聯合促銷與聯合行銷交易結構

第4章 聯合促銷與聯合行銷交易的主導

• 簡介
• 主要的聯合促銷與聯合行銷交易，各金額

第5章 -最活躍的聯合促銷與聯合行銷的交易廠商主要25公司

• 簡介
• 最活躍的聯合促銷與聯合行銷的交易廠商主要25公司

第6章 -包含契約名錄的聯合促銷與聯合行銷交易

• 簡介
• 聯合促銷與聯合行銷交易，2016年～2025年
• 交易名錄
• 交易名錄 - 聯合促銷與聯合行銷交易(AZ)，各企業
• 交易名錄 - 聯合促銷與聯合行銷交易，各治療領域
• 交易名錄 - 聯合促銷與聯合行銷交易，各科技類型
• 關於調查公司
• 目前聯盟
• 目前契約
• Current Partnering的最近報告標題

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-promotion and co-marketing deals.

Fully revised and updated, the report provides details of co-promotion and co-marketing deals from 2016 to 2025.

The report provides access to co-promotion and co-marketing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of co-promotion and co-marketing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of co-promotion and co-marketing dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in co-promotion and co-marketing as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of co-promotion and co-marketing deals.

Chapter 4 provides a review of the leading co-promotion and co-marketing deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active co-promotion and co-marketing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of co-promotion and co-marketing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the co-promotion and co-marketing deal.

The deal directory includes a comprehensive listing of all co-promotion and co-marketing deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in co-promotion and co-marketing dealmaking since 2016.

In conclusion, this report provides everything a prospective dealmaker needs to know about co-promotion and co-marketing alliances.

Key benefits

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse co-promotion and co-marketing deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the co-promotion and co-marketing trends and structure of deals entered into by leading biopharma companies worldwide.

Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology includes:

• Trends in co-promotion and co-marketing dealmaking in the biopharma industry
• Overview of co-promotion and co-marketing deal structure
• Directory of co-promotion and co-marketing deal records covering pharmaceutical and biotechnology
• The leading co-promotion and co-marketing deals by value
• Most active co-promotion and co-marketing dealmakers
• The leading co-promotion and co-marketing partnering resources

In Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for co-promotion and co-marketing deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-promotion and co-marketing dealmaking

• 2.1. Introduction
• 2.2. Definition of co-promotion and co-marketing deals
• 2.3. Trends in co-promotion and co-marketing deals since 2016
  • 2.3.1. Co-promotion and co-marketing dealmaking by year, 2016-2025
  • 2.3.2. Co-promotion and co-marketing dealmaking by phase of development, 2016-2025
  • 2.3.3. Co-promotion and co-marketing dealmaking by industry sector, 2016-2025
  • 2.3.4. Co-promotion and co-marketing dealmaking by therapy area, 2016-2025
  • 2.3.5. Co-promotion and co-marketing dealmaking by technology type, 2016-2025
  • 2.3.6. Co-promotion and co-marketing dealmaking by most active company, 2016-2025
• 2.4. Reasons for entering into co-promotion and co-marketing partnering deals
• 2.5. The future of co-promotion and co-marketing deals

Chapter 3 - Overview of co-promotion and co-marketing deal structure

• 3.1. Introduction
• 3.2. Co-promotion and co-marketing agreement structure

Chapter 4 - Leading co-promotion and co-marketing deals

• 4.1. Introduction
• 4.2. Top co-promotion and co-marketing deals by value

Chapter 5 - Top 25 most active co-promotion and co-marketing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-promotion and co-marketing dealmakers

Chapter 6 - Co-promotion and co-marketing deals including contracts directory

• 6.1. Introduction
• 6.2. Co-promotion and co-marketing deals with contracts 2016-2025
• Deal directory
• Deal directory - Co-promotion and co-marketing dealmaking by companies A-Z
• Deal directory - Co-promotion and co-marketing dealmaking by therapy area
• Deal directory - Co-promotion and co-marketing dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-promotion and co-marketing
• Figure 2: Trends in co-promotion and co-marketing deal announcements, 2016-2025
• Figure 3: Co-promotion and co-marketing deals signed at each phase of development, 2016-2025
• Figure 4: Co-promotion and co-marketing deals by industry sector, 2016-2025
• Figure 5: Co-promotion and co-marketing deals by therapy area, 2016-2025
• Figure 6: Co-promotion and co-marketing deals by technology type, 2016-2025
• Figure 7: Top 25 most active co-promotion and co-marketing dealmakers, 2016-2025
• Figure 8: Top co-promotion and co-marketing deals by value, 2016-2025
• Figure 9: Most active co-promotion and co-marketing dealmakers, 2016-2025